News

News

Icon LISA News = LISA News
08.06.2022
Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate, Host Symposium at NECTM8
08.06.2022
Valneva Joins Euronext’s Tech Leaders Index
08.06.2022
Europäische Leitlinien „made in Tyrol“ für häufigste Erbkrankheit
07.06.2022
Weiss-Forschungspreis: Neue Erkenntnisse in der Frühgeborenen-Forschung
07.06.2022
Valneva to Present and Hold Investor Meetings at the Jefferies US Healthcare Conference
07.06.2022
Preclinical Data on Novel Arenaviral HIV Therapeutic Vaccines Presented at Keystone Symposium
07.06.2022
HOOKIPA announces positive Phase 1 data and Phase 2 plans for HB-200 program for the treatment of advanced head and neck cancers at ASCO
07.06.2022
Gezielte Mikroernährung lindert Symptome bei Allergien
03.06.2022
Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders
03.06.2022
Valneva Announces the Availability of Documentation for its Shareholder Meetings